APD
59
2
WU
32
2
GIS
31
3
CRM
67
2
FTI
81
5
PBI
69
4
DD
63
3
SIG
52
3
LMT
34
2
GT
62
6
NWS
66
-3
LLY
37
-3
DG
6
2
XYL
49
4
VZ
50
3
CL
58
2
LEG
36
4
BF.B
33
2
URI
65
5
PSX
47
2
APD
59
2
WU
32
2
GIS
31
3
CRM
67
2
FTI
81
5
PBI
69
4
DD
63
3
SIG
52
3
LMT
34
2
GT
62
6
NWS
66
-3
LLY
37
-3
DG
6
2
XYL
49
4
VZ
50
3
CL
58
2
LEG
36
4
BF.B
33
2
URI
65
5
PSX
47
2
Financhill
Back

Chugai Pharmaceutical 10K Form

Sell
41

CHGCF
Chugai Pharmaceutical

Last Price:
38.46
Seasonality Move:
3.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CHGCF News And Ratings

See the #1 stock for the next 7 days that we like better than CHGCF

CHGCF Financial Statistics

Sales & Book Value

Annual Sales: $7.92B
Cash Flow: $749.99M
Price / Cash Flow: 26.18
Annual Sales: $6.62
Price / Book: 5.81

Profitability

EPS (TTM): 1.56390
Net Income (TTM): $2.57B
Gross Margin: $4.98B
Return on Equity: 21.98%
Return on Assets: 20.1%

Chugai Pharmaceutical Earnings Forecast

Key Chugai Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 21 years for CHGCF is 62.81%.
  • The Selling, General & Administrative Expenses for CHGCF have been equal to 10.13% of Gross Profit Margin.
  • The Research & Development expenses have been 15.73% of Revenue.
  • The Interest Expense is 0.01% of Operating Income.
  • The Net Earning history of CHGCF is 29.29% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 13 years.

Chugai Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CHGCF
Website: chugai-pharm.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.09
Quick Ratio: 4.02

Price-to-Earnings

Trailing P/E Ratio: 27.28
Forward P/E Ratio: 0

CHGCF Technical Analysis vs Fundamental Analysis

Sell
41
Chugai Pharmaceutical (CHGCF) is a Sell

Is Chugai Pharmaceutical a Buy or a Sell?